BMJ· Weiqing Wang, Yu Xu, Fengmei Xu, Huanfeng Pan, Xiuqin Geng, Yufang Li, Yifei He, Guihong Xing, Jieli Lu, Tiange Wang, Yan Liu, Tingzhi Li, Peng Duan, Qian Zhang, Jiangmin Wang, Yonghui Zhao, Ping Lu, Ruizhi Zheng, Yuhong Chen, Songbo Fu, Shengli Wu, Weihong Chen, Hongting Zheng, Juan Deng, Shengdi Chen, Jun Liu, Binyin Li, Weiguo Hu, Shujing Wu, Jingya Niu, Jingya Wang, Qi Zhou, Leshan Liu, Xiaolu Wang, Yusen Zhou, Dekuan Liu, Qiuyun Li, Deyu Shang, Airong Zheng, Chunfang Zhang, Yuchen Xu, Jiqiu Wang, Xiadi He, Siyu Wang, Zhihong Wang, Guoyue Yuan, Jijun Peng, Peixia Cui, Suijun Wang, Hongbo Dang, Fuhua Yan, Naying He, Qin Wan, Jian Yang, Yu Liu, Guang Ning, Mian Li, Yufang Bi·· 5 天前精选AI 评分58
BPROAD预设分析:强化降压未显著改善2型糖尿病患者的认知结局
Effect of intensive blood pressure control on cognitive outcomes and brain structures in adults with type 2 diabetes: prespecified analysis of secondary outcomes of BPROAD randomised controlled trial
AI 导读
BPROAD随机对照试验的预设次要结局分析显示,在12821名≥50岁、伴收缩压升高和心血管风险增高的2型糖尿病患者中,强化降压(目标SBP<120 mm Hg)与标准降压(目标SBP<140 mm Hg)相比,全因痴呆或轻度认知障碍复合结局无显著差异(HR 0.96,95%CI 0.86-1.06;P=0.38)。
推荐理由
BPROAD试验预设分析显示,强化降压未显著降低2型糖尿病患者的认知障碍风险,为降压目标与认知结局的关系提供了大样本随机证据。
来源:BMJ · bmj.com